EODData

MEMBERSHIP REGISTER LOG IN

ASX, CU6: Clarity Pharmaceuticals Ltd.

05 Nov 2025
LAST:

4.610

CHANGE:
 0.23		OPEN:
4.860		HIGH:
4.870		ASK:
3.420		VOLUME:
1.86M
CHG(%):
4.75		PREV:
4.840		LOW:
4.440		BID:
3.370		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
05 Nov 254.8604.8704.4404.6101.86M
04 Nov 254.8504.9704.7304.8401.76M
03 Nov 254.9605.1004.7304.8202.06M
31 Oct 254.8705.1404.6704.9002.76M
30 Oct 254.6004.9504.5554.8202.01M
29 Oct 254.5904.6704.5304.6101.39M
28 Oct 254.5104.6404.3304.5701.66M
27 Oct 254.5504.7404.4504.5201.88M
24 Oct 254.6704.7204.4504.5101.72M
23 Oct 254.7104.7104.5604.5901.32M

COMPANY PROFILE

Name:Clarity Pharmaceuticals Ltd.
About:Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States. The company's lead product is SAR-bisPSMA, a theranostic radiopharmaceutical for the treatment of Prostate Specific Membrane Antigen (PSMA) cancer. It also develops SAR-Bombesin, a pan cancer theranostic radiopharmaceutical to treat prostate, breast, ovarian, urinary, small cell lung cancer, as well as glioblastoma and gastrointestinal stromal tumours; and SARTATE, a theranostic radiopharmaceutical for the treatment of somatostatin receptor 2 (SSTR2) cancer. The company was incorporated in 2010 and is based in Sydney, Australia.
Sector:Healthcare
Industry:Biotechnology
Address:National Innovation Centre, Sydney, NSW, Australia, 2015
Website:https://www.claritypharmaceuticals.com
ISIN:AU0000165375
FIGI:BBG011WVJ0K9

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-24.08 
Forward P/E:-53.56 
PEG Ratio:-53.56 
Price to Sales:192.59 
Price to Book:17.15 
Operating Margin:-8.23 
Return on Assets:-0.34 
Return on Equity:-0.54 
EPS Ratio:-0.20 
Revenue:9.46M 
Shares:371.93M 
Market Cap:1.715B 

TECHNICAL INDICATORS

MA5:4.804.1%
MA10:4.681.5%
MA20:4.885.8%
MA50:4.1311.6%
MA100:3.7722.1%
MA200:3.2044.0%
STO9:15.87 
STO14:12.35 
RSI14:27.89 
WPR14:-74.36
MTM14:-0.27
ROC14:-0.06 
ATR:0.33 
Week High:5.1411.5%
Week Low:4.443.8%
Month High:5.8727.3%
Month Low:4.3344.0%
Year High:7.6866.6%
Year Low:1.43222.4%
Volatility:22.04